home / stock / kpti / kpti quote
Last: | $0.89 |
---|---|
Change Percent: | 0.82% |
Open: | $0.91 |
Close: | $0.89 |
High: | $0.9231 |
Low: | $0.8621 |
Volume: | 815,486 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.89 | $0.91 | $0.89 | $0.9231 | $0.8621 | 815,486 | 07-19-2024 |
$0.9175 | $0.9693 | $0.9175 | $0.9986 | $0.916 | 1,000,660 | 07-18-2024 |
$0.98 | $0.99 | $0.98 | $1.04 | $0.9512 | 903,431 | 07-17-2024 |
$1 | $0.97 | $1 | $1.02 | $0.961 | 1,677,062 | 07-16-2024 |
$0.9684 | $0.96 | $0.9684 | $0.9969 | $0.9103 | 1,946,478 | 07-15-2024 |
$0.9435 | $0.9625 | $0.9435 | $1.02 | $0.9403 | 847,184 | 07-12-2024 |
$0.9624 | $0.8979 | $0.9624 | $0.9654 | $0.871 | 593,540 | 07-11-2024 |
$0.8666 | $0.84 | $0.8666 | $0.8954 | $0.831 | 434,114 | 07-10-2024 |
$0.8436 | $0.7925 | $0.8436 | $0.8593 | $0.7702 | 1,485,894 | 07-09-2024 |
$0.7901 | $0.83 | $0.7901 | $0.8505 | $0.7851 | 1,338,911 | 07-08-2024 |
$0.8187 | $0.851 | $0.8187 | $0.851 | $0.7919 | 883,519 | 07-05-2024 |
$0.8282 | $0.8317 | $0.8282 | $0.8718 | $0.8146 | 541,408 | 07-04-2024 |
$0.8282 | $0.8317 | $0.8282 | $0.8718 | $0.8146 | 541,408 | 07-03-2024 |
$0.8 | $0.8218 | $0.8 | $0.843 | $0.785 | 2,085,672 | 07-02-2024 |
$0.8155 | $0.89 | $0.8155 | $0.9135 | $0.8155 | 1,799,241 | 07-01-2024 |
$0.8676 | $0.9526 | $0.8676 | $1.0199 | $0.8676 | 14,292,954 | 06-28-2024 |
$0.9731 | $0.9917 | $0.9731 | $1.03 | $0.9588 | 1,375,427 | 06-27-2024 |
$0.9951 | $1.07 | $0.9951 | $1.15 | $0.98 | 1,088,789 | 06-26-2024 |
$1.09 | $1.1 | $1.09 | $1.115 | $1.05 | 1,278,917 | 06-25-2024 |
$1.1 | $0.97 | $1.1 | $1.16 | $0.9679 | 2,023,671 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
Karyopharm Therapeutics Inc. Company Name:
KPTI Stock Symbol:
NASDAQ Market:
Karyopharm Therapeutics Inc. Website:
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates PR Newswire Long-Term Follow-Up Data Signal Promising Progression-Free S...
Karyopharm to Participate at the Jefferies Global Healthcare Conference PR Newswire NEWTON, Mass. , May 29, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announ...